Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 11Thoracic 2Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Tobacco Use Disorder 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Neoplasm Metastasis 1Melanoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Radiosurgery 9Magnetic Resonance Spectroscopy 6pembrolizumab 4Radiotherapy 4Nivolumab 4Fluorodeoxyglucose F18 4cabozantinib 3Specimen Handling 3Paclitaxel 3Melphalan 3Ipilimumab 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Busulfan 3lenvatinib 2entrectinib 2cediranib 2Thiotepa 2Sunitinib 2Radiation 2Peripheral Blood Stem Cell Transplantation 2Injections 2Ifosfamide 2FAPI-46 2Etoposide 2Carboplatin 2Bone Marrow Transplantation 2Bevacizumab 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Memantine × Genitourinary × Clear all
NCT04588246 2026-05-20

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

NRG Oncology

Phase 3 Terminated
19 enrolled 19 charts
BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡